No Data
No Data
Acrobiosystems Co.,Ltd.'s (SZSE:301080) Most Bullish Insider, CEO Yiding Chen Must Be Pleased With the Recent 10% Gain
Key Insights AcrobiosystemsLtd's significant insider ownership suggests inherent interests in company's expansion A total of 5 investors have a majority stake in the company with 51% ownership In
Pepsis (301080.SZ): Net profit of 306.721 million yuan in the first quarter decreased by 31.91% year-on-year
On April 23, GLONGHUI (301080.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 146 million yuan, up 6.67% year on year; net profit attributable to shareholders of listed companies was 306.721 million yuan, down 31.91% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 30.2819 million yuan, down 32.12% year on year; basic earnings per share were 0.2561 yuan.
ACROBiosystems Lanza Soluciones Organoides 3D, Impulsando Nuevas Fronteras En La Investigación Bioterapéutica
BASILEA, Suiza, 10 de abril de 2024 /PRNewswire/ -- A partir de 2023, ACROBiosystems ha estado lanzando un flujo continuo de productos innovadores relacionados con organoides. Al mostrar sus avances
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research
Acrobiosystems Co.,Ltd.'s (SZSE:301080) Intrinsic Value Is Potentially 18% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, AcrobiosystemsLtd fair value estimate is CN¥38.62 AcrobiosystemsLtd's CN¥47.34 share price signals that it might be 23% overvalued Analyst
ACROBiosystems Launches New Initiative to Support Cell and Gene Manufacturers
ACROBiosystems, one of the leading providers of innovative tools and solutions used from discovery to the clinic, has announced a new corporate...
No Data